Biosensors Market by Type (Embedded Device, Sensor Patch), Technology (Electrochemical Biosensors, Nanomechanical Biosensors, Optical Biosensors), Product, Industry - Global Forecast 2023-2030
The Biosensors Market is projected to reach USD 77.73 billion by 2030 from USD 30.36 billion in 2022, at a CAGR of 12.46% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biosensors Market.
- Based on Type, market is studied across Embedded Device and Sensor Patch. The Embedded Device commanded largest market share of 86.36% in 2022, followed by Sensor Patch.
- Based on Technology, market is studied across Electrochemical Biosensors, Nanomechanical Biosensors, Optical Biosensors, Piezoelectric Biosensors, and Thermal Biosensors. The Optical Biosensors is further studied across Colorimetric Biosensors, Fluorescence Biosensors, and SPR. The Piezoelectric Biosensors is further studied across Acoustic Biosensors and Microcantilever Biosensors. The Electrochemical Biosensors commanded largest market share of 35.12% in 2022, followed by Thermal Biosensors.
- Based on Product, market is studied across Nonwearable Biosensors and Wearable Biosensors. The Wearable Biosensors is further studied across Bodywear, Eyewear, Footwear, Neckwear, and Wristwear. The Nonwearable Biosensors commanded largest market share of 75.46% in 2022, followed by Wearable Biosensors.
- Based on Industry, market is studied across Biodefense, Environmental Monitoring, Food & Beverages, Home Diagnostics, POC, and Research Lab. The Home Diagnostics is further studied across Cholesterol Testing Kit, Glucose Monitoring Kit, and Pregnancy Testing Kit. The POC is further studied across Blood Gas & Electrolyte Detection, Cardiac Marker, Cholesterol Testing, Coagulation Monitoring, Glucose Monitoring, Infectious Disease Detection, Pregnancy Testing, Tumor Or Cancer Marker, and Urinalysis Testing. The POC commanded largest market share of 32.34% in 2022, followed by Home Diagnostics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 36.28% in 2022, followed by Americas.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Biosensors Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Biosensors Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Biosensors Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACON Laboratories, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Biosensors International Group, Ltd., DuPont de Nemours, Inc., Ercon Inc., F. Hoffmann-La Roche AG, GE Healthcare, LifeScan, Inc., Medtronic PLC, Nova Biomedical Corporation, Siemens AG, Sysmex Corporation, and Universal Biosensors Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Biosensors Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Biosensors Market?
- What is the competitive strategic window for identifying opportunities in the Biosensors Market?
- What are the latest technology trends and regulatory frameworks in the Biosensors Market?
- What is the market share of the leading vendors in the Biosensors Market?
- Which modes and strategic moves are suitable for entering the Biosensors Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Biosensors Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Emergence of Nanotechnology-Based Biosensors
- 5.1.1.2. Significant Technological Advancements in Recent Years
- 5.1.1.3. Growing use of Biosensors to Monitor Glucose Levels in Individuals with Diabetes
- 5.1.1.4. Rising Demand for Home-Based POC Devices
- 5.1.1.5. Government Initiatives Toward Diagnostics
- 5.1.2. Restraints
- 5.1.2.1. Slow Rate of Commercialization Coupled by Reluctance Toward Adoption of New Treatment Practices
- 5.1.2.2. High Investment in R&D
- 5.1.3. Opportunities
- 5.1.3.1. Growth Opportunities in Developing Countries
- 5.1.3.2. Increasing Demand in Food Industry, Environmental Monitoring, and Biodefense
- 5.1.4. Challenges
- 5.1.4.1. Government Regulations Results in Long Certification and Approval Cycles
- 5.1.4.2. Pricing pressure in POC market
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Biosensors Market, by Type
- 6.1. Introduction
- 6.2. Embedded Device
- 6.3. Sensor Patch
- 7. Biosensors Market, by Technology
- 7.1. Introduction
- 7.2. Electrochemical Biosensors
- 7.3. Nanomechanical Biosensors
- 7.4. Optical Biosensors
- 7.5.1. Colorimetric Biosensors
- 7.5.2. Fluorescence Biosensors
- 7.5.3. SPR
- 7.5. Piezoelectric Biosensors
- 7.6.1. Acoustic Biosensors
- 7.6.2. Microcantilever Biosensors
- 7.6. Thermal Biosensors
- 8. Biosensors Market, by Product
- 8.1. Introduction
- 8.2. Nonwearable Biosensors
- 8.3. Wearable Biosensors
- 8.4.1. Bodywear
- 8.4.2. Eyewear
- 8.4.3. Footwear
- 8.4.4. Neckwear
- 8.4.5. Wristwear
- 9. Biosensors Market, by Industry
- 9.1. Introduction
- 9.2. Biodefense
- 9.3. Environmental Monitoring
- 9.4. Food & Beverages
- 9.5. Home Diagnostics
- 9.6.1. Cholesterol Testing Kit
- 9.6.2. Glucose Monitoring Kit
- 9.6.3. Pregnancy Testing Kit
- 9.6. POC
- 9.7.1. Blood Gas & Electrolyte Detection
- 9.7.2. Cardiac Marker
- 9.7.3. Cholesterol Testing
- 9.7.4. Coagulation Monitoring
- 9.7.5. Glucose Monitoring
- 9.7.6. Infectious Disease Detection
- 9.7.7. Pregnancy Testing
- 9.7.8. Tumor Or Cancer Marker
- 9.7.9. Urinalysis Testing
- 9.7. Research Lab
- 10. Americas Biosensors Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Biosensors Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Biosensors Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories Inc.
- 14.1.2. ACON Laboratories, Inc.
- 14.1.3. Bayer AG
- 14.1.4. Bio-Rad Laboratories, Inc.
- 14.1.5. Biosensors International Group, Ltd.
- 14.1.6. DuPont de Nemours, Inc.
- 14.1.7. Ercon Inc.
- 14.1.8. F. Hoffmann-La Roche AG
- 14.1.9. GE Healthcare
- 14.1.10. LifeScan, Inc.
- 14.1.11. Medtronic PLC
- 14.1.12. Nova Biomedical Corporation
- 14.1.13. Siemens AG
- 14.1.14. Sysmex Corporation
- 14.1.15. Universal Biosensors Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook